Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Hui-xiao Fu"'
Autor:
Yin-zhi Xu, Zhao-yuan Xu, Hui-xiao Fu, Mao Yue, Jia-qun Li, Chang-peng Cui, Di Wu, Bai-yan Li
Publikováno v:
Biomolecules, Vol 14, Iss 10, p 1311 (2024)
Multi-drug therapies are common in cardiovascular disease intervention; however, io channel/pump coordination has not been tested electrophysiologically. Apparently, inward currents were not elicited by Yoda1/10 nM or Dobutamine/100 nM alone in Ah-ty
Externí odkaz:
https://doaj.org/article/b44705933a9346828d7b74e2e9af6400
Autor:
Fan Sun, Heng Liu, Hui-xiao Fu, Cheng-bo Li, Xiao-jing Geng, Xiao-xuan Zhang, Jiang Zhu, Zheng Ma, Yan-jun Gao, Zhi-jie Dou
Publikováno v:
Frontiers in Neurology, Vol 11 (2020)
Background: Ischemic stroke has a poor prognosis and brings a ponderous burden on families and society. Hemorrhagic transformation (HT) after intravenous thrombolysis can increase the mortality of patients with ischemic stroke. Thus, finding new HT b
Externí odkaz:
https://doaj.org/article/45e2e13e093a49269a8c1abaef865e6d
Autor:
Fan Sun, Heng Liu, Hui-xiao Fu, Shuo Zhang, Xu-dong Qian, Jia-jia Li, Yun-bo Zhu, Xiao-xuan Zhang, Jian Zhang, Hai-peng Qiu, Ling-ling Kang, Ya-jun Hu, Liang Zhao, Yan-juan Mi, Yan-jun Gao, Zhi-jie Dou, Zheng Ma
Publikováno v:
Journal of International Medical Research, Vol 48 (2020)
Objective Cerebral infarction has a poor prognosis and causes a serious burden on families and society. Recombinant tissue plasminogen activator (rt-PA) and urokinase (UK) are commonly used thrombolytic agents in the clinic. However, direct and power
Externí odkaz:
https://doaj.org/article/3c17e1be62084a70944c4bb43e952f2b
Autor:
Yan-Jun Gao, Cheng-Bo Li, Hui-Xiao Fu, Jiang Zhu, Zheng Ma, Zhi-Jie Dou, Heng Liu, Fan Sun, Xiao-Jing Geng, Xiao-Xuan Zhang
Publikováno v:
Frontiers in Neurology
Frontiers in Neurology, Vol 11 (2020)
Frontiers in Neurology, Vol 11 (2020)
Background: Ischemic stroke has a poor prognosis and brings a ponderous burden on families and society. Hemorrhagic transformation (HT) after intravenous thrombolysis can increase the mortality of patients with ischemic stroke. Thus, finding new HT b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d837426c27adbca0b755a086e7b3037d
Autor:
Xu-Dong Qian, Yan-Juan Mi, Hui-Xiao Fu, Jia-Jia Li, Liang Zhao, Ya-Jun Hu, Hai-Peng Qiu, Zhi-Jie Dou, Heng Liu, Zheng Ma, Shuo Zhang, Yan-Jun Gao, Ling-Ling Kang, Fan Sun, Yun-Bo Zhu, Xiao-Xuan Zhang, Jian Zhang
Publikováno v:
Journal of International Medical Research, Vol 48 (2020)
The Journal of International Medical Research
The Journal of International Medical Research
Objective Cerebral infarction has a poor prognosis and causes a serious burden on families and society. Recombinant tissue plasminogen activator (rt-PA) and urokinase (UK) are commonly used thrombolytic agents in the clinic. However, direct and power
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3367908b5c357b4bfc3bcb813dcaec75
https://doaj.org/article/3c17e1be62084a70944c4bb43e952f2b
https://doaj.org/article/3c17e1be62084a70944c4bb43e952f2b